Enter your contact details & our Business Development
expert will circle back to address your request!
In 2021, the market for Foot Ulcer Sensors worldwide was worth $ 9.20 billion US dollars. AMR Group projects that the market will reach US$ 15.3 billion by 2031, growing at a CAGR of 6.5 percent between 2022 and 2031.
Patients who have lost their sense of protective sensation, such as those affected by diabetic neuropathy, frequently develop foot ulcers as a result of repetitive damage to the feet. The main contributor to the worldwide disability burden is diabetes-related foot disorders (DFD), which are generally defined as foot ulcers, infections, and gangrene. For people at risk for DFD, high plantar pressures, an irregular gait, hyperglycemia, hypertension, and dyslipidemia are important risk factors for complications and recurrence of DFD. It is now possible to offer remote treatment to people who are at risk for DFD thanks to the utilization of telehealth management and a number of sensors and wearables that have been created before or are being created now.
One of the most serious consequences that a diabetic person might experience is a diabetic foot ulcer since their body's ability to repair wounds is greatly diminished. It is the development of a wound, typically on the patient's foot, that undergoes rapid disintegration and encourages the growth of pathogenic germs there. The majority of diabetes patients depend on a few generic drugs that they must regularly take in order to keep their blood sugar levels under control. External insulin infusion into the body is one of them. Due to the minor injuries that occur during the injection process, these patients frequently report having a diabetic foot ulcer. Furthermore, one of the most serious complications of diabetes mellitus is diabetic foot ulcer, which is also likely the main feature of the diabetic foot. One of the most important medical problems in the world currently is diabetic foot ulcers. In order to prevent amputation, the treatment of diabetic foot ulcers aims for quick healing and wound closure through the use of a multimodal therapeutic strategy. The foot ulcer sensors include biosensors, optical sensors, thermal sensors, RGB sensors, flexiforce sensors, and red-green-blue (RGB) sensors. These sensors are primarily used for self-management and foot monitoring to detect the first signs of foot ulcers, keep track of existing ulcers, and rule out potential recurrence ulcerations. The sensors are employed to locate the DFD-related symptoms. Temperature change, color change (extreme redness), skin damage from uneven foot plantar pressure, swelling or odor, or a change in pain level are the signs and symptoms.
The global Foot Ulcer Sensors market is expected to grow due to the prevalence of chronic diseases and the availability of favourable government initiatives as well as reimbursement frameworks. Furthermore, the evolution of low-cost medical devices & technological advancements in medical sensors are expected to boost demand for Foot Ulcer Sensors during the forthcoming years, allowing middle-income and low-income countries to gain access to diagnostic devices. Chronic noncommunicable diseases (NCDs) account for approximately 80% of mortality in China among adults aged 60, with Ischemic Heart Disease, Stroke, Chronic Obstructive Pulmonary Disease (COPD), and Type 2 Diabetes being the most common.
By permitting the production of more contemporary equipment that incorporates cutting-edge technologies and components, technological developments are fueling the market for Foot Ulcer Sensors because they raise the danger of issues that are widely prevalent in society. The development of a diabetic foot ulcer is the most serious consequence associated with modern living. This causes a complex wound that is extremely difficult to heal in the foot region of the person's lower limbs because of its incapacity to repair itself. Management of such a wound becomes extremely difficult due to the difficulty of cleaning such wounds and rinsing them with the essential solutions. Moreover, high costs as well as a specialized labor are needed for the development and manufacturing of sensors.
The COVID-19 pandemic benefited the Foot Ulcer Sensors industry. The COVID-19 pandemic had become a worldwide health crisis, causing significant burden of diseases and financial adversity in several sectors of the world's economy. However, it was noticed to be a favorable year for the Foot Ulcer Sensors market due to its benefits during the pandemic period. Furthermore, the widespread use of wearables in the detection of COVID-19 symptoms, as well as the rising amount of FDA-approved product lines, are expected to drive the market. According to the National Diabetes Statistical Report, which the Centers for Disease Control and Prevention released in June 2022, there are approximately 37.3 million individuals worldwide who have diabetes, with the United States accounting for 11.3% of those cases. In general, 5% of diabetes mellitus patients experience foot ulcers, and 1% require an amputation.
Geographically, North America dominated the Foot Ulcer Sensors market, accounting of total revenue in 2022. By the end of 2025, the number of diabetics in the UK is expected to reach 5 million from the current 3.3 million. The NHS spends over USD 1.38 billion annually on treating diabetic foot ulcers. In England, there are over 60,000 diabetic foot ulcer patients, 160-foot ulcer-related amputations occur per week, and more than 60% of these patients pass away within five years of having their feet amputated.
Because of the region's increased demand for advanced sensor, the Asia-Pacific region is predicted to present exceptional Foot Ulcer Sensors market potential. Furthermore, during the forecast period, the industry is anticipated to profit from improved healthcare infrastructure as well as an increase in the number of medical providers in this region for the forecasted period.
Key players operating in the Foot Ulcer Sensors Market include 3M Company, B. Braun Melsungen AG, Cardinal Health Inc., Coloplast Group, ConvaTec Group Plc., Kerecis, Medline Industries, Inc., MiMedx, Mölnlycke Health Care AB., Organogenesis Inc., Smith & Nephew and URGO among others. In 2020, for the purpose of improving remote patient monitoring for patients at risk, BioIntelliSense & Philips forged a strategic partnership. In order to reduce the incidence of diabetic foot ulcers, Orpyx Medical Technologies released Orpyx Sensory Insoles in December 2019. These insoles incorporate remote patient monitoring. This technique is anticipated to avoid neuropathic ulcers as well.
There are several commercially available devices, such as the Pedar and F-Scan systems, that can measure the plantar pressure in the foot. Yet only athletes in the professional ranks can afford these systems. In-shoe sensors are tiny implants that monitor the force applied to the bottom of the foot.
The Foot Ulcer Sensors market is divided into five Types: Optical Sensors, Thermal Sensors, Red-Green-Blue (RGB) Sensors, Flexi Force Sensors, And Biosensors. thermal sensors or RGB sensors dominates the type segment, with the largest market share in 2022. Its dominance over the forecast period is due to extensive manufacturing advancement.
The Foot Ulcer Sensors market is divided into four segments based on application: Foot Deformities /Wounds, Glucose Levels, Hemoglobin Concentrations, and Temperature. The most dominant market in the application segment is foot temperature, which is the most useful technique used in identification. The Foot Ulcer Sensors market is further subdivided into Hospitals and specialty clinics end users.
• Optical Sensors
• Thermal Sensors
• Red-Green-Blue (RGB) Sensors
• Flexi Force Sensors
• Foot Deformities/Wounds
• Glucose Levels
• Hemoglobin Concentrations
By End User
• Specialty Clinics
Please fill form below:
99 WALL STREET #2124 NEW YORK, NY 10005